GLOBAL Down Syndrome Foundation Blog
Dr. Kishore Vellody
What Families Need to Know! A Pediatrician’s Tips for Understanding Common Lab Results
Posted on June 06, 2023
Medicare Limits Coverage of Controversial Alzheimer’s Drug to Those in Clinical Trials
Medicare Limits Coverage of Controversial Alzheimer’s Drug to Those in Clinical Trials CNN | Apr 08, 2022
Posted on April 08, 2022
For People With Down Syndrome, A Longer Life, But Under A Cloud
For People With Down Syndrome, A Longer Life, But Under A Cloud The Washington Post | Apr 07, 2022
Posted on April 07, 2022
More Lawmakers Ratchet Up Pressure on CMS to Overturn Aduhelm Coverage Proposal
More Lawmakers Ratchet Up Pressure on CMS to Overturn Aduhelm Coverage Proposal Fierce Healthcare | Apr 04, 2022
Posted on April 04, 2022
GLOBAL’s Position Statement on Humanitarian Crisis in Ukraine
Global Down Syndrome Foundation has been following the developments and grave humanitarian crisis taking place in Ukraine. We are all deeply concerned for the men, women, children, elderly, and people with disabilities who are being forced to leave their homes due to the conflict and those who are still trying to escape Ukraine to neighboring […]
Posted on March 29, 2022
National Coverage Determination May Limit Access to AD Treatment
National Coverage Determination May Limit Access to AD Treatment HealthPayerIntelligence | Mar 14, 2022
Posted on March 14, 2022
Medicare Proposal on Alzheimer’s Drug Draws Criticism From Drugmakers
Medicare Proposal on Alzheimer’s Drug Draws Criticism From Drugmakers The Wall Street Journal | Feb 23, 2022
Posted on February 23, 2022
Alzheimer’s patients ‘devastated’ at Medicare limits on drug critics say needs more testing
Alzheimer’s patients ‘devastated’ at Medicare limits on drug critics say needs more testing USA Today | Feb 18, 2022
Posted on February 18, 2022